Getagraph.com logo
NASDAQ Composite: ( 0.65%) 16 795
S&P 500 Futures
(-0.03%) 5 330.00 points
Dow Jones Futures
(0.03%) 39 957 points
Nasdaq Futures
(-0.19%) 18 727 points
Oil
(-1.63%) $78.50
Gas
(-2.73%) $2.68
Gold
(-0.31%) $2 430.90
Silver
(-1.41%) $31.97
Platinum
(-0.24%) $1 061.20
USD/EUR
(0.15%) $0.922
USD/NOK
(-0.10%) $10.69
USD/GBP
(0.11%) $0.788
USD/RUB
(-0.42%) $90.29

Realaus laiko atnaujinimai Pluri Inc. [PLUR]

Birža: NASDAQ Global Market Sektorius: Healthcare Pramonė: Biotechnology
Upcoming Earnings Alert

Quarter results today
(bmo 2024-05-21)

Expected move: +/- 0.00%

Atnaujinta20 geg. 2024 @ 23:00
25% discount on Stockinvest.us - Use code: Podcast

-2.26% $ 6.05

Live Chart Being Loaded With Signals

Commentary (20 geg. 2024 @ 23:00):

Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions...

Stats
Šios dienos apimtis 3 777.00
Vidutinė apimtis 28 146.00
Rinkos kapitalizacija 32.60M
EPS $0 ( 2024-05-08 )
Kita pelno data ( $0 ) 2024-06-25
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.300
ATR14 $0.181 (2.99%)
Insider Trading
Date Person Action Amount type
2024-01-23 Franco-yehuda Chen Buy 355 000 Common Stock
2024-01-23 Aberman Zami Buy 44 100 Common Stock
2024-01-23 Birger Pinhas Doron Buy 39 900 Common Stock
2024-01-23 Shemesh-rasmussen Maital Buy 38 150 Common Stock
2024-01-23 Yanay Yaky Buy 700 000 Common Stock
INSIDER POWER
99.92
Last 95 transactions
Buy: 8 548 074 | Sell: 1 004 814

Pluri Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Pluri Inc. Finansinės ataskaitos

Annual 2023
Pajamos: $287 000
Bruto pelnas: $278 000 (96.86 %)
EPS: $-6.18
FY 2023
Pajamos: $287 000
Bruto pelnas: $278 000 (96.86 %)
EPS: $-6.18
FY 2022
Pajamos: $234 000
Bruto pelnas: $-41.36M (-17 674.79 %)
EPS: $-1.270
FY 2021
Pajamos: $0.00
Bruto pelnas: $0.00 (0.00 %)
EPS: $-1.770

Financial Reports:

No articles found.

Pluri Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Pluri Inc.

Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.